Drawing for INTO ACCELERATING INHALATION DEVELOPMENT

USPTO serial 79363031

INTO ACCELERATING INHALATION DEVELOPMENT

Reviewed by CopyMark Law Group

Reg. 7416390Status 700Registered
Filing date
Status date
Registration date
Jun 18, 2024
Examiner
BERNS, LEE ANNE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INTO ACCELERATING INHALATION DEVELOPMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, chemical additives and chemical compositions, namely, active chemical ingredients and excipients for use in the manufacture of pharmaceuticals for treating respiratory diseases; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, and use in the manufacture of pharmaceuticalsACTIVE
005Pharmaceuticals, pharmaceutical preparations, pharmaceuticals for medical or veterinary purposes, pharmaceutical compositions, vaccines and medicine being pharmaceutical preparations, all for use in the treatment of respiratory diseasesACTIVE
042Pharmaceutical and chemical research services; pharmaceutical and chemical product development services for others; pharmaceutical and chemical design services being pharmaceutical and chemical product development services for others; testing of pharmaceuticals and chemicals; medical and scientific research, namely, conducting clinical trials of pharmaceuticals for others and testing of chemicals; pharmaceutical and chemical analysis; laboratory research services relating to orally inhaled and nasal drugs products; pharmaceutical and chemical product evaluation; preparation of reports in the nature of technical writing relating to the aforesaid pharmaceutical and chemical research; inspection being testing and inspection of pharmaceuticals and chemicals; scientific and technological services, namely, scientific research, formulation development, analysis and testing in the field of orally inhaled and nasal drugs products; biological research services; quality control for others and authentication services for pharmaceuticals; information, advice and consultancy services in relation to the aforesaid servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 2, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 22, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 27, 2024XXSSGENERIC MADRID TRANSACTION SENT TO IB
Nov 27, 2024XXCRGENERIC MADRID TRANSACTION CREATED
Sep 18, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 18, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 16, 2024GPNXNOTIFICATION PROCESSED BY IB
Apr 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2024XAECEXAMINER'S AMENDMENT ENTERED
Feb 23, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Feb 23, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 13, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2023RFNTREFUSAL PROCESSED BY IB
Sep 27, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2023RFRRREFUSAL PROCESSED BY MPU
Sep 11, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2023DOCKASSIGNED TO EXAMINER
Feb 22, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Feb 18, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance